Principal Securities’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-400
Closed -$225K 1455
2025
Q4
$225K Buy
400
+6
+2% +$3.41K ﹤0.01% 1273
2025
Q3
$203K Sell
394
-23
-6% -$10K ﹤0.01% 1279
2025
Q2
$131K Buy
417
+50
+14% +$15K ﹤0.01% 1424
2025
Q1
$122K Hold
367
﹤0.01% 1343
2024
Q4
$122K Buy
367
+75
+26% +$25.4K ﹤0.01% 1343
2024
Q3
$97.5K Buy
292
+45
+18% +$17.1K ﹤0.01% 1410
2024
Q2
$102K Sell
247
-2
-0.8% -$792 ﹤0.01% 1324
2024
Q1
$101K Buy
249
+28
+13% +$9.85K ﹤0.01% 1274
2023
Q4
$67.7K Buy
+221
New +$59.7K ﹤0.01% 1347

Other funds holding MEDP

Principal Securities's MEDP Position: Q1 2026 in Review

Principal Securities sold out of Medpace (MEDP) in Q1 2026, closing a stake of 400 shares — an estimated $225K sold.

Principal Securities first reported a position in MEDP in Q4 2023 and held it in 9 quarters. The position peaked at $225K in Q4 2025. 733 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Principal Securities reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
  • Principal Securities sold 400 Medpace shares in Q1 2026, an estimated $225K.
  • Principal Securities first reported a position in Medpace in Q4 2023 and held it in 9 quarters.
  • Principal Securities's Medpace position peaked at $225K in Q4 2025.
  • 733 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Principal Securities's 13F filing for Q1 2026, filed 13 May 2026.